Immunotherapeutic Targeting of Human Malignancy: Pilot Studies with Epstein-Barr Virus-Positive Nasopharyngeal Carcinoma

Project Details

Short titleImmunotherapeutic Targeting of Human Malignancy: Pilot Studies with Epstein-Barr Virus-Positive Nasopharyngeal Carcinoma
StatusFinished
Effective start/end date1/04/0230/04/05

Funding

  • Cancer Research UK